{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:09:37Z","timestamp":1778962177138,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.eimce.2022.08.009","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T07:32:39Z","timestamp":1673681559000},"page":"69-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibiotic susceptibility and genotypic characterization of Neisseria gonorrhoeae isolates in the Comunidad Valenciana (Spain): GONOvig project"],"prefix":"10.1016","volume":"42","author":[{"given":"Aleix Borja","family":"Fabregat Bolufer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Bueno Ferrando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Navarro Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Colomina Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2022.08.009_bib0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ."},{"key":"10.1016\/j.eimce.2022.08.009_bib0010","unstructured":"European Centre for Disease Prevention and Control. Gonorrhoea: Annual Epidemiological Report for 2018 [accessed 4 Jul 2022]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/gonorrhoea-annual-epidemiological-report-2018.pdf; 2020."},{"key":"10.1016\/j.eimce.2022.08.009_bib0015","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s Treatment Guidelines for Gonococcal Infection, 2020","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.eimce.2022.08.009_bib0020","first-page":"1018","article-title":"2020 European guideline for the diagnosis and treatment of gonorrhoea in adults","volume":"32","author":"Unemo","year":"2020","journal-title":"Int J STD AIDS."},{"key":"10.1016\/j.eimce.2022.08.009_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0956462419886775","article-title":"2018 UK national guideline for the management of infection with Neisseria gonorrhoeae","volume":"31","author":"Fifer","year":"2020","journal-title":"Int J STD AIDS."},{"key":"10.1016\/j.eimce.2022.08.009_bib0030","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/JCM.01453-07","article-title":"Concordance between Neisseria gonorrhoeae genotypes recovered from known sexual contacts","volume":"45","author":"Bilek","year":"2007","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimce.2022.08.009_bib0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/sti.2008.029694","article-title":"Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing","volume":"84","author":"Palmer","year":"2008","journal-title":"Sex Transm Infect."},{"key":"10.1016\/j.eimce.2022.08.009_bib0040","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1128\/JCM.01236-09","article-title":"First Neisseria gonorrhoeae genotyping analysis in France: identification of a strain cluster with reduced susceptibility to ceftriaxone","volume":"47","author":"Monfort","year":"2009","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimce.2022.08.009_bib0045","unstructured":"World Health Organization (WHO). 2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline [accessed 14 Jul 2022]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/330420\/9789240000193-eng.pdf; 2019."},{"key":"10.1016\/j.eimce.2022.08.009_bib0050","first-page":"534","article-title":"Comparative study of MALDI-TOF MS and VITEK 2 in bacteria identification","volume":"6","author":"Guo","year":"2014","journal-title":"J Thorac Dis."},{"key":"10.1016\/j.eimce.2022.08.009_bib0055","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100. (ISBN 978-1-68440-066-9 [Print]; ISBN 978-1-68440-067-6 [Electronic])."},{"key":"10.1016\/j.eimce.2022.08.009_bib0060","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0 [accessed 6 Jul 2022]. Available from: http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_10.0_Breakpoint_Tables.pdf; 2020."},{"key":"10.1016\/j.eimce.2022.08.009_bib0065","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/383047","article-title":"Rapid sequence\u2010based identification of gonococcal transmission clusters in a large metropolitan area","volume":"189","author":"Martin","year":"2004","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimce.2022.08.009_bib0070","doi-asserted-by":"crossref","first-page":"20358","DOI":"10.2807\/ese.18.03.20358-en","article-title":"Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone","volume":"18","author":"Chisholm","year":"2013","journal-title":"Eurosurveillance."},{"key":"10.1016\/j.eimce.2022.08.009_bib0075","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1093\/jac\/dkw279","article-title":"WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC &2 mg\/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014","volume":"71","author":"Jacobsson","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimce.2022.08.009_bib0080","unstructured":"World Health Organization. 2018 Report on global sexually transmitted infection surveillance [accessed 6 Jul 2022]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/277258\/9789241565691-eNG.pdf; 2018."},{"key":"10.1016\/j.eimce.2022.08.009_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES.2019.24.8.1900118","article-title":"Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018","volume":"24","author":"Jennison","year":"2019","journal-title":"Eurosurveillance."},{"key":"10.1016\/j.eimce.2022.08.009_bib0090","unstructured":"European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe \u2013 Results summary 2017 [accessed 6 Jul 2022]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Euro-GASP-2017.pdf; 2019."},{"key":"10.1016\/j.eimce.2022.08.009_bib0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.eimc.2013.03.010","article-title":"Neisseria gonorrhoeae: antimicrobial resistance and study of population dynamics. Situation in Barcelona in 2011","volume":"31","author":"Serra-Pladevall","year":"2013","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.eimce.2022.08.009_bib0100","unstructured":"Serra Pladevall J. Neisseria gonorrhoeae: monitoritzaci\u00f3 de la sensibilitat antimicrobiana, estudi de la din\u00e0mica poblacional i caracteritzaci\u00f3 molecular de les resist\u00e8ncies. 2016 [accessed 6 Jul 2022]. Available from: http:\/\/hdl.handle.net\/10803\/400390."},{"key":"10.1016\/j.eimce.2022.08.009_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eimc.2015.01.017","article-title":"Antimicrobial susceptibility and typing of Neisseria gonorrhoeae strains from Southern Spain, 2012-2014","volume":"34","author":"Cobo","year":"2016","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.eimce.2022.08.009_bib0110","first-page":"114","article-title":"Typing and antimicrobial susceptibility of 134 Neisseria gonorrhoeae strains from Southern Spain","volume":"32","author":"Cobo","year":"2019","journal-title":"Rev Esp Quimioter."},{"key":"10.1016\/j.eimce.2022.08.009_bib0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.eimc.2019.12.002","article-title":"Antimicrobial susceptibility study of Neisseria gonorrhoeae in the health area of the University and Polytechnic La Fe Hospital of Valencia","volume":"38","author":"Casta\u00f1o Aroca","year":"2020","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.eimce.2022.08.009_bib0120","unstructured":"European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe \u2013 Results summary 2018. 2020 [accessed 7 Jul 2022]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/gonococcal-antimicrobial-susceptibility-Euro-GASP-2018-Erratum.pdf."},{"key":"10.1016\/j.eimce.2022.08.009_bib0125","unstructured":"European Centre for Disease Prevention and Control. Molecular typing of Neisseria gonorrhoeae \u2013 a study of 2013 isolates. 2018 [accessed 7 Jul 2022]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Molecular-typiNG-N-gonorrhoeae-web.pdf."},{"key":"10.1016\/j.eimce.2022.08.009_bib0130","first-page":"8","article-title":"Sorveglianza di laboratorio del l\u2019antibiotico-resistenza in Neisseria gonorrhoeae: risultati del biennio 2016-2017","volume":"32","author":"Carannante","year":"2019","journal-title":"Not Ist Super Sanit\u00e0."},{"key":"10.1016\/j.eimce.2022.08.009_bib0135","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimce.2022.08.009_bib0140","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain","volume":"67","author":"C\u00e1mara","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimce.2022.08.009_bib0145","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010","volume":"16","author":"Ison","year":"2011","journal-title":"Eurosurveillance."},{"key":"10.1016\/j.eimce.2022.08.009_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002366","article-title":"Multidrug-resistant gonorrhea: a research and development roadmap to discover new medicines","volume":"14","author":"Alirol","year":"2017","journal-title":"PLoS Med."}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X23000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X23000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:50:20Z","timestamp":1778961020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X23000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2529993X23000011"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2022.08.009","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic susceptibility and genotypic characterization of Neisseria gonorrhoeae isolates in the Comunidad Valenciana (Spain): GONOvig project","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2022.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2022.08.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}